Alison DeDent, MD
Assistant Professor
Medicine
School of Medicine

Dr. Alison DeDent specializes in pulmonary and critical care medicine and sub-specializes in interstitial lung disease. She attends in the UCSF Interstitial Lung Disease (ILD) Clinic, the UCSF and Zuckerberg San Francisco General (ZSFG) Medical Intensive Care Unit (ICU), the UCSF Neuro ICU, and the ZSFG Fellow's Chest Clinic.

Show full bio (50 words) Hide full bio

Her clinical research focuses on identifying, understanding, and addressing geographic (rural and low-income urban) and socioeconomic health disparities in interstitial lung disease (ILD) using implementation science, with the goal of designing innovative telehealth interventions that seek to improve health equity, access to care, and outcomes in vulnerable populations with ILD.

Awards

Show all (1) Hide

• Alpha Omega Alpha Honor Medical Society, University of Toledo College of Medicine, 2014

Education & Training

Show all (6) Hide

• MAS Master's Degree in Clinical Research University of California, San Francisco 2022
• Diversity, Equity, and Inclusion Champion Training University of California, San Francisco 2020
• Clinical Fellowship Pulmonary and Critical Care Medicine University of California, San Francisco 2020
• Residency Internal Medicine University of Colorado 2017
• MD University of Toledo College of Medicine 2014
• BS Biology The Ohio State University 2009

Interests

Show all (7) Hide

• Health Services Research
• Health Disparities
• Interstital Lung Disease
• General Pulmonary Medicine
• Implementation Science
• Intensive Care
• Telehealth

Grants and Projects

Show all (3) Hide

• Implementation of a Virtual Interstitial Lung Disease Multidisciplinary Team Meeting with Providers Practicing in Underserved Areas: a Pilot Study, Nina Ireland Foundation for Lung Health, 2023-2025
• Development of a Telehealth Intervention Targeting Barriers to Early Guideline-Concordant Idiopathic Pulmonary Fibrosis Care for Rural Populations, Pulmonary Fibrosis Foundation PFF Scholars, 2022-2024
• Telehealth Expansion and Access to Interstitial Lung Disease Specialty Care for Rural Populations, American Thoracic Society Award in Interstitial Lung Disease, 2023-2024

Publications (7)

Top publication keywords:
HumansCarbon MonoxidePatient AcuityRural PopulationVital CapacityAir PollutionLung Diseases, InterstitialIdiopathic Pulmonary FibrosisVaccinesProportional Hazards ModelsPyridonesVeteransVaccinationMedicareRetrospective Studies

• Neighborhood Health and Outcomes in Idiopathic Pulmonary Fibrosis.
  Annals of the American Thoracic Society 2024 DeDent AM, Collard HR, Thakur N
• Disparities in Antifibrotic Medication Utilization Among Veterans With Idiopathic Pulmonary Fibrosis.
  Chest 2023 Kaul B, Lee JS, Petersen LA, McCulloch C, Rosas IO, Bandi VD, Zhang N, DeDent AM, Collard HR, Whooley MA
• Disparities in Rural Populations With Idiopathic Pulmonary Fibrosis.
  Chest 2022 DeDent AM, Collard HR, Thakur N
• Relative environmental and social disadvantage in patients with idiopathic pulmonary fibrosis.
  Thorax 2021 Avitzur N, Noth EM, Lamidi M, Nathan SD, Collard HR, DeDent AM, Thakur N, Johannson KA
• Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination.
  Thorax 2021 DeDent AM, Farrand E
• In: Wuyts WA, Cottin V, Spagnolo P, et al., eds. Pulmonary Manifestations of Systemic Diseases (ERS Monograph)
  Interstitial pneumonia with autoimmune features. 2019 DeDent AM, Fischer A
• Posterior Reversible Encephalopathy Syndrome Secondary to CSF Leak and Intracranial Hypotension: A Case Report and Literature Review.
  Case reports in neurological medicine 2015 Hammad T, DeDent A, Algahtani R, Alastal Y, Elmer L, Medhkour A, Safi F, Assaly R